## Why Disproportionately reduced DLCO (<50% predicted) is right Combined Pulmonary Fibrosis and Emphysema (CPFE) syndrome is characterized by a physiological paradox: lung volumes appear pseudo-normalized because emphysema-induced hyperinflation and fibrosis-induced deflation cancel each other out. This makes TLC and spirometric volumes unreliable for diagnosis. The MOST SENSITIVE and specific finding is a disproportionately LOW DLCO (<50% predicted), which reflects the combined effect of emphysematous destruction of alveolar-capillary surface area and fibrotic thickening of the alveolar-capillary membrane. DLCO is the key discriminator that separates CPFE from pure COPD (where DLCO is mildly reduced) or pure IPF (where DLCO is reduced but not as severely in early disease). Harrison 21e Ch 287 and ATS/ERS 2022 guidelines emphasize DLCO as the most sensitive parameter for CPFE diagnosis. ## Why each distractor is wrong - **Elevated FEV1/FVC ratio on repeat spirometry**: CPFE presents with a REDUCED FEV1/FVC ratio (<0.70) due to the obstructive component. An elevated ratio would argue against airflow obstruction and would be inconsistent with the mixed pattern. This is a reversal of the actual physiology. - **Increased TLC on body plethysmography**: CPFE does NOT show increased TLC. The hallmark is that TLC is reduced (<80% predicted) due to the restrictive fibrotic component, even though it appears pseudo-normalized clinically. An increased TLC would suggest pure emphysema or hyperinflation, not CPFE. - **Normal or near-normal lung volumes on imaging**: While CPFE may show relatively preserved lung volumes on standard imaging due to the cancellation effect, this is NOT the most sensitive diagnostic parameter. HRCT findings (upper-lobe emphysema + lower-lobe UIP pattern) are required for diagnosis, but DLCO remains the most sensitive physiological marker for confirming the severity and presence of the syndrome. **High-Yield:** In CPFE, DLCO <50% is the physiological hallmark because it reflects BOTH emphysematous destruction AND fibrotic thickening—the two pathological processes that define the syndrome. [cite: Harrison 21e Ch 287; ATS/ERS Interpretive Strategies 2022]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.